Patent revoked
Patent revoked, The patent has been granted, Grant of patent is intended, Examination is in progress, Request for examination was made
EP Register Verified
DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST
Publication No.
EP3453387
•
App No.
EP18201062
•
Filed by
Novartis AG
•
Filed on
2009-12-21
•
Issued/Published on
2020-06-03
Publication No.
EP3453387
A1
Application No.
EP18201062
Filed: 2009-12-21
Grant Date
2020-06-03
Mention of grant
Active Oppositions
4 Active
EPO Oppositions
Patent Abstract / Summary
S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage.
IPC Classifications
A61K31/137, A61P37/00, A61P37/06, A61K31/135, A61K31/138, A61K31/661
A61K31/137, A61P37/00, A61P37/06
Priority Claims
US 20080139672P
Date: 2008-12-22
US 20090218530P
Date: 2009-06-19
US 20090246715P
Date: 2009-09-29
Designated Contracting States (36 EPC States)
AT
BE
BG
CH
CY
CZ
DE
DK
EE
ES
FI
FR
GB
GR
HR
HU
IE
IS
IT
LI
LT
LU
LV
MC
MK
MT
NL
NO
PL
PT
RO
SE
SI
SK
SM
TR
Parties & Representation
Applicants
Novartis AG
Lichtstrasse 35, 4056 Basel
CHInventors (4)
SCHMOUDER, Robert
Novartis Pharmaceuticals Corporation, One Health Plaza
USDUMORTIER, Thomas
Novartis Pharma AG, Postfach
CHDAVID, Olivier
Novartis Pharma AG, Postfach
CHLOOBY, Michael
Novartis Pharma AG, Postfach
CHRepresentatives / Agents
Elkington and Fife LLP
Prospect House, 8 Pembroke Road
GBWiessner, Michael
Novartis Pharma AG, Patent Department
CHHamm&Wittkopp Patentanwälte PartmbB
Jungfernstieg 38, 20354 Hamburg
DEDr. Schön, Neymeyr & Partner Patentanwälte mbB
Bavariaring 26, 80336 Munich
DEDr. Schoen, Neymeyr & Partner Patentanwälte mbB
Bavariaring 26, 80336 Munich
DEKey Procedural Dates
Request-For-Examination
2018-11-14
First-Examination-Report-Despatched
2019-04-15
Patent Oppositions
Official opposition proceedings filed against European Patent EP3453387 under EPC Article 99.
#1
Opponent
Company
von Seebach, Malte
Jungfernstieg 38, DE
Representative
Hamm&Wittkopp Patentanwälte PartmbB
Filing
Date
Opposition in Progress
2021-03-03
#2
Opponent
Company
Hamm&Wittkopp Patentanwälte PartmbB
Jungfernstieg 38, DE
Representative
Hamm&Wittkopp Patentanwälte PartmbB
Filing
Date
Opposition in Progress
2021-03-03
#3
Opponent
Company
Laboratorios Liconsa, S.A.
Gran Via Carlos III, 98, 7th floor, ES
Representative
Dr. Schön, Neymeyr & Partner Patentanwälte mbB
Filing
Date
Opposition in Progress
2021-03-03
#4
Opponent
Company
Laboratorios Liconsa, S.A.
Gran Via Carlos III, 98, 7th floor, ES
Representative
Dr. Schoen, Neymeyr & Partner Patentanwälte mbB
Filing
Date
Opposition in Progress
2021-03-03
Legal Status & Event History
Official European Patent Office legal and procedural status changes recorded for this file.
| Date | Code | Event Description | Auth |
|---|---|---|---|
| 2019-03-13 | 17P | REQUEST FOR EXAMINATION FILED | EP |
| 2019-03-13 | AC | DIVISIONAL APPLICATION: REFERENCE TO EARLIER APPLICATION | EP |
| 2019-03-13 | AK | DESIGNATED CONTRACTING STATES | EP |
| 2019-03-13 | AX | REQUEST FOR EXTENSION OF THE EUROPEAN PATENT | EP |
| 2019-05-15 | 17Q | FIRST EXAMINATION REPORT DESPATCHED | EP |
| 2019-10-09 | RAX | REQUESTED EXTENSION STATES OF THE EUROPEAN PATENT HAVE CHANGED | EP |
| 2019-10-09 | RBV | DESIGNATED CONTRACTING STATES (CORRECTED) | EP |
| 2020-04-15 | RIC1 | INFORMATION PROVIDED ON IPC CODE ASSIGNED BEFORE GRANT | EP |
| 2020-04-29 | INTG | INTENTION TO GRANT ANNOUNCED | EP |
| 2020-04-29 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2020-06-03 | AX | REQUEST FOR EXTENSION OF THE EUROPEAN PATENT | EP |
| 2020-06-03 | AC | DIVISIONAL APPLICATION: REFERENCE TO EARLIER APPLICATION | EP |
| 2020-06-03 | AK | DESIGNATED CONTRACTING STATES | EP |
| 2020-06-03 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2020-06-15 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2020-06-25 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2020-08-10 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2020-08-18 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2020-08-14 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2020-08-24 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2020-08-23 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2020-10-15 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2020-10-21 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2020-11-03 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2020-07-27 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2020-08-03 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2020-08-11 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2020-12-25 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2020-12-11 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2020-05-01 | GRAA | (EXPECTED) GRANT | EP |
| 2020-03-30 | GRAP | DESPATCH OF COMMUNICATION OF INTENTION TO GRANT A PATENT | EP |
| 2020-04-22 | GRAS | GRANT FEE PAID | EP |
| 2021-03-09 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2021-03-03 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2021-04-07 | 26 | OPPOSITION FILED | EP |
| 2019-02-08 | PUAI | PUBLIC REFERENCE MADE UNDER ARTICLE 153(3) EPC TO A PUBLISHED INTERNATIONAL APPLICATION THAT HAS ENTERED THE EUROPEAN PHASE | EP |
| 2020-05-01 | STAA | INFORMATION ON THE STATUS OF AN EP PATENT APPLICATION OR GRANTED EP PATENT | EP |
| 2020-03-30 | STAA | INFORMATION ON THE STATUS OF AN EP PATENT APPLICATION OR GRANTED EP PATENT | EP |
| 2019-04-10 | STAA | INFORMATION ON THE STATUS OF AN EP PATENT APPLICATION OR GRANTED EP PATENT | EP |
| 2019-02-08 | STAA | INFORMATION ON THE STATUS OF AN EP PATENT APPLICATION OR GRANTED EP PATENT | EP |
| 2021-04-28 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2021-04-06 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2021-05-19 | R26 | OPPOSITION FILED (CORRECTED) | EP |
| 2021-07-27 | PLBB | REPLY OF PATENT PROPRIETOR TO NOTICE(S) OF OPPOSITION RECEIVED | EP |
| 2021-04-16 | PLAB | OPPOSITION DATA, OPPONENT'S DATA OR THAT OF THE OPPONENT'S REPRESENTATIVE MODIFIED | EP |
| 2021-03-15 | PLAX | NOTICE OF OPPOSITION AND REQUEST TO FILE OBSERVATION + TIME LIMIT SENT | EP |
| 2021-03-05 | PLBI | OPPOSITION FILED | EP |
| 2022-01-07 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2022-07-15 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2023-01-20 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2023-06-21 | P01 | OPT-OUT OF THE COMPETENCE OF THE UNIFIED PATENT COURT (UPC) REGISTERED | EP |
| 2023-12-22 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2024-09-06 | PLBP | OPPOSITION WITHDRAWN | EP |
| 2024-10-18 | PLBP | OPPOSITION WITHDRAWN | EP |
| 2024-11-08 | PLBP | OPPOSITION WITHDRAWN | EP |
| 2024-12-15 | RDAF | COMMUNICATION DESPATCHED THAT PATENT IS REVOKED | EP |
| 2025-01-10 | APBP | DATE OF RECEIPT OF NOTICE OF APPEAL RECORDED | EP |
| 2025-01-03 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2024-10-09 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2025-04-16 | APBQ | DATE OF RECEIPT OF STATEMENT OF GROUNDS OF APPEAL RECORDED | EP |
| 2025-04-16 | APAW | APPEAL REFERENCE DELETED | EP |
| 2025-04-29 | APAH | APPEAL REFERENCE MODIFIED | EP |
| 2025-12-15 | PGFP | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | EP |
| 2026-01-01 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2026-01-02 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2026-01-08 | PGFP | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | EP |
| 2026-01-09 | PGFP | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | EP |
| 2026-01-12 | PGFP | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | EP |
| 2026-01-13 | PGFP | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | EP |
| 2026-01-14 | PGFP | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | EP |
| 2026-01-15 | PGFP | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | EP |
| 2026-01-16 | PGFP | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | EP |
| 2026-01-19 | PGFP | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | EP |
| 2026-01-20 | PGFP | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | EP |
| 2026-01-22 | PGFP | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | EP |
| 2026-01-23 | PGFP | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | EP |
| 2026-01-26 | PGFP | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | EP |
| 2026-01-27 | PGFP | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | EP |
| 2026-01-30 | PGFP | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | EP |
| 2026-03-03 | APBU | APPEAL PROCEDURE CLOSED | EP |
| 2026-03-06 | RDAG | PATENT REVOKED | EP |
| 2026-03-06 | STAA | INFORMATION ON THE STATUS OF AN EP PATENT APPLICATION OR GRANTED EP PATENT | EP |
| 2026-03-11 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2026-02-27 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2026-03-25 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2026-04-08 | 27W | PATENT REVOKED | EP |
| 2026-04-08 | GBPR | GB: PATENT REVOKED UNDER ART. 102 OF THE EP CONVENTION DESIGNATING THE UK AS CONTRACTING STATE | EP |
| 2026-04-10 | PGFP | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | EP |
| 2026-04-15 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2026-04-08 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2026-04-23 | PGFP | ANNUAL FEE PAID TO NATIONAL OFFICE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | EP |
| 2026-05-08 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2026-05-15 | REG | REFERENCE TO A NATIONAL CODE | EP |
| 2026-07-10 | PG25 | LAPSED IN A CONTRACTING STATE [ANNOUNCED VIA POSTGRANT INFORMATION FROM NATIONAL OFFICE TO EPO] | EP |
| 2026-08-11 | REG | REFERENCE TO A NATIONAL CODE | EP |
Patent & Non-Patent Citations
Cited documents and prior art referenced in search and examination reports.
Cited Patent Documents
EP0627406
1994-12-07
Espacenet
WO0218395
2002-03-07
Espacenet
WO03097028
2003-11-27
Espacenet
WO2006058316
2006-06-01
Espacenet
WO2009048993
2009-04-16
Espacenet
WO2009155475
2009-12-23
Espacenet
WO2009115954
2009-09-24
Espacenet
EP18201062
Espacenet
WO2010075239
Espacenet
WO2010072703
2010-07-01
Espacenet
Non-Patent Scientific Literature (NPL)
- MEHLING M; BRINKMANN V; ANTEL J; BAR-OR A; GOEBELS N; VEDRINE C; KRISTOFIC C; KUHLE J; LINDBERG RL; KAPPOS L: "FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis", NEUROLOGY, vol. 71, no. 16, 14 October 2008 (2008-10-14), pages 1261 - 7, XP009165260, DOI: doi:10.1212/01.wnl.0000327609.57688.ea
- KAPPOS L; ANTEL J; COMI G; MONTALBAN X; O'CONNOR P; POLMAN CH; HAAS T; KORN AA; KARLSSON G; RADUE EW: "Oral fingolimod (FTY720) for relapsing multiple sclerosis", N ENGL J MED, vol. 355, no. 11, 14 September 2006 (2006-09-14), pages 1124 - 40
- ROBERT SCHMOUDER; DENISE SERRA; YIBIN WANG; JOHN M. KOVARIK; JOHN DIMARCO; THOMAS L. HUNT; MARIE-CLAUDE BASTIEN: "FTY720: Placebo-Controlled Study of the Effect on Cardiac Rate and Rhythm in Healthy Subjects", J. CLIN. PHARMACOL., vol. 46, 2006, pages 895, XP008107801, DOI: doi:10.1177/0091270006289853
- SCHMOULDER R., ET AL.: "Multiple Sclerosis", vol. 14, part Abst P507 17 September 2008, SAGE, London, article ORAL FINGOLIMOD (FTY720), 0.5 OR 1.25 MG, FOR 14 DAYS HAS NO EFFECT ON CARDIAC FUNCTION: "World Congresson Treatment and Research on Multiple Sclerosis", pages: S177, XP009127649
- BUDDE K ET AL: "First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients", JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, WILLIAMS AND WILKINS, BALTIMORE, MD, US, vol. 13, no. 4, 1 January 2002 (2002-01-01), pages 1073 - 1083, XP003016978, ISSN: 1046-6673
- KOYRAKH LEV ET AL: "The heart rate decrease caused by acute FTY720 administration is mediated by the G protein-gated potassium channel I.", March 2005, AMERICAN JOURNAL OF TRANSPLANTATION : OFFICIAL JOURNAL OF THE AMERICAN SOCIETY OF TRANSPLANTATION AND THE AMERICAN SOCIETY OF TRANSPLANT SURGEONS MAR 2005, VOL. 5, NR. 3, PAGE(S) 529 - 536, ISSN: 1600-6135, XP002562406
- DAVID KINSHUCK AT HEARTOFENGLAND NHS UK: "Blood pressure and diabetes", 4 December 2006 (2006-12-04), XP055086741, Retrieved from the Internet <URL:http://medweb.bham.ac.uk/easdec/prevention/Diabetes%20and%20Blood%20Pressure.htm> [retrieved on 20131105]
- V. BRINKMANN: "Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology", PHARMACOLOGY & THERAPEUTICS, vol. 115, 2007, pages 84 - 105, XP022134156, DOI: 10.1016/j.pharmthera.2007.04.006
- B.A. BROWN ET AL.: "Fingolimod: A Novel Immunosuppressant for Multiple Sclerosis", THE ANNALS OF PHARMACOTHERAPY, vol. 41, 2007, pages 1660 - 1668, XP009121784, DOI: 10.1345/aph.1G424
- B. POIRIER ET AL.: "A G protein-biased SIP i agonist, SAR247799, protects endothelial cells without affecting lymphocyte numbers", SCI. SIGNAL., vol. 13, 2020, pages 1 - 13, XP055976677
- LUBLIN FRED; MILLER DAVID H; FREEDMAN MARK S; CREE BRUCE A C; WOLINSKY JERRY S; WEINER HOWARD; LUBETZKI CATHERINE; HARTUNG HANS-PE: "Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial", THE LANCET, ELSEVIER, AMSTERDAM, NL, vol. 387, no. 10023, 28 January 2016 (2016-01-28), AMSTERDAM, NL , pages 1075 - 1084, XP029442340, ISSN: 0140-6736, DOI: 10.1016/S0140-6736(15)01314-8
- H. TEDESCO-SILVA ET AL.: "FTY720, A Novel Immunomodulator: Efficacy and Safety Results from the First Phase 2A Study in de novo Renal Transplantation", TRANSPLANTATION, vol. 79, no. 11, 2005, pages 1553 - 1560, XP055976680
- L. KAPPOS ET AL.: "Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis", N. ENGL. J. MED., vol. 355, 2006, pages 1124 - 1140, XP009072986, DOI: 10.1056/NEJMoa052643
- TOMOHIKO HARADA; DARREN WILBRAHAM; GUILLEMETTE LA BORDERIE; SHINSUKE INOUE; JIM BUSH; A. JOHN CAMM: "Cardiac effects of amiselimod compared with fingolimod and placebo: results of a randomised, parallel‐group, phase I study in healthy subjects", BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, BLACKWELL SCIENTIFIC PUBL., GB, vol. 83, no. 5, 19 January 2017 (2017-01-19), GB , pages 1011 - 1027, XP071602953, ISSN: 0306-5251, DOI: 10.1111/bcp.13203
- S. KROSSER ET AL.: "Effect of Ceralifimod (ONO-4641) on Lymphocytes and Cardiac Function: Randomized, Double-Blind, Placebo-Controlled Trial With an Open-Label Fingolimod Arm", J. OF CLIN. PHARMACOL., vol. 55, no. 9, 2015, pages 1051 - 1060, XP055976691
- HOBSON DOUGLAS E., POURCHER EMMANUELLE, MARTIN W.R. WAYNE: "Ropinirole and Pramipexole, the New Agonists", CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, WINNIPEG, CA, vol. 26, no. S2, 1 August 1999 (1999-08-01), CA , pages S27 - S33, XP055923472, ISSN: 0317-1671, DOI: 10.1017/S0317167100000068
- J.A. DESMEULES: "The tramadol option", EUR. J. PAIN, vol. 4, 2000, XP008068602, DOI: 10.1053/eujp.1999.0163
* , and *
- ANONYMOUS: "Treatment guidelines for preventive treatment of migraine", ACTA NEUROL TAIWAN, vol. 17, no. 2, 1 June 2008 (2008-06-01), pages 132 - 148, XP055976695
* , abstract (article in Chinese). *
Worldwide Patent Family
Related applications and patents in the same INPADOC worldwide family.
| Country | Publication Number | Kind | Publication Date | Action |
|---|---|---|---|---|
| EP | EP3453387A1 | A1 | 2019-03-13 | Espacenet |
| EP | EP3453387B1 | B1 | 2020-06-03 | Espacenet |
| AR | AR074826A1 | A1 | 2011-02-16 | Espacenet |
| AU | AU2009330176A1 | A1 | 2011-07-07 | Espacenet |
| AU | AU2009330176B2 | B2 | 2014-03-06 | Espacenet |
| AU | AU2009330176C1 | C1 | 2016-12-08 | Espacenet |
| AU | AU2009330176C9 | C9 | 2017-01-05 | Espacenet |
| BR | BRPI0923500A2 | A2 | 2018-05-29 | Espacenet |
| CA | CA2747802A1 | A1 | 2010-07-01 | Espacenet |
| CA | CA2747802C | C | 2021-02-09 | Espacenet |
| CL | CL2011001529A1 | A1 | 2012-02-24 | Espacenet |
| CL | CL2013001558A1 | A1 | 2013-10-25 | Espacenet |
| CN | CN102264359A | A | 2011-11-30 | Espacenet |
| CO | CO6390117A2 | A2 | 2012-02-29 | Espacenet |
| CR | CR20110274A | A | 2011-07-19 | Espacenet |
| CU | CU20110136A7 | A7 | 2012-01-31 | Espacenet |
| CU | CU20130155A7 | A7 | 2014-02-28 | Espacenet |
| CY | CY1116990T1 | T1 | 2017-04-05 | Espacenet |
| CY | CY1122812T1 | T1 | 2021-05-05 | Espacenet |
| CY | CY1123255T1 | T1 | 2021-10-29 | Espacenet |
| CY | CY2020036I1 | I1 | 2021-03-12 | Espacenet |
| CY | CY2020036I2 | I2 | 2021-06-25 | Espacenet |
| CY | CY2025012I1 | I1 | 2026-02-25 | Espacenet |
| CY | CY2025012I2 | I2 | 2026-02-25 | Espacenet |
| DK | DK2379067T3 | T3 | 2015-12-07 | Espacenet |
| DK | DK3409274T3 | T3 | 2019-12-16 | Espacenet |
| DK | DK3453387T3 | T3 | 2020-08-10 | Espacenet |
| DK | DK4098256T3 | T3 | 2025-04-22 | Espacenet |
| DK | DK4098256T5 | T5 | 2025-07-21 | Espacenet |
| EA | EA201100978A1 | A1 | 2012-01-30 | Espacenet |
| EC | ECSP11011222A | A | 2011-08-31 | Espacenet |
| EP | EP2379067A1 | A1 | 2011-10-26 | Espacenet |
| EP | EP2379067B1 | B1 | 2015-09-02 | Espacenet |
| EP | EP2907511A1 | A1 | 2015-08-19 | Espacenet |
| EP | EP3120844A1 | A1 | 2017-01-25 | Espacenet |
| EP | EP3409274A1 | A1 | 2018-12-05 | Espacenet |
| EP | EP3409274B1 | B1 | 2019-11-20 | Espacenet |
| EP | EP3677260A1 | A1 | 2020-07-08 | Espacenet |
| EP | EP4098256A1 | A1 | 2022-12-07 | Espacenet |
| EP | EP4098256B1 | B1 | 2025-02-26 | Espacenet |
| EP | EP4098256B9 | B9 | 2025-06-18 | Espacenet |
| ES | ES2552823T3 | T3 | 2015-12-02 | Espacenet |
| ES | ES2760607T3 | T3 | 2020-05-14 | Espacenet |
| ES | ES2810823T3 | T3 | 2021-03-09 | Espacenet |
| ES | ES3017254T3 | T3 | 2025-05-12 | Espacenet |
| FI | FI4098256T3 | T3 | 2025-03-31 | Espacenet |
| FI | FIC20253002I1 | I1 | 2025-05-23 | Espacenet |
| FR | FR20C1060I1 | I1 | 2020-12-25 | Espacenet |
| FR | FR25C1012I1 | I1 | 2025-06-13 | Espacenet |
| HN | HN2011001759A | A | 2013-11-26 | Espacenet |
| HR | HRP20151190T1 | T1 | 2016-01-01 | Espacenet |
| HR | HRP20192175T1 | T1 | 2020-03-20 | Espacenet |
| HR | HRP20201167T1 | T1 | 2020-12-11 | Espacenet |
| HR | HRP20250568T1 | T1 | 2025-07-04 | Espacenet |
| HU | HUE026869T2 | T2 | 2016-08-29 | Espacenet |
| HU | HUE048717T2 | T2 | 2020-08-28 | Espacenet |
| HU | HUE048717T4 | T4 | 2022-02-28 | Espacenet |
| HU | HUE052048T2 | T2 | 2021-04-28 | Espacenet |
| HU | HUE071189T2 | T2 | 2025-08-28 | Espacenet |
| HU | HUS2000046I1 | I1 | 2020-12-28 | Espacenet |
| HU | HUS2500026I1 | I1 | 2025-07-28 | Espacenet |
| IL | IL274756A | A | 2020-07-30 | Espacenet |
| IL | IL278914A | A | 2021-01-31 | Espacenet |
| JP | JP2012513401A | A | 2012-06-14 | Espacenet |
| JP | JP2014144970A | A | 2014-08-14 | Espacenet |
| JP | JP2016135752A | A | 2016-07-28 | Espacenet |
| JP | JP2017141238A | A | 2017-08-17 | Espacenet |
| JP | JP2019167360A | A | 2019-10-03 | Espacenet |
| JP | JP7329965B2 | B2 | 2023-08-21 | Espacenet |
| JP | JP2022103194A | A | 2022-07-07 | Espacenet |
| JP | JP2024129030A | A | 2024-09-26 | Espacenet |
| KR | KR20110096175A | A | 2011-08-29 | Espacenet |
| KR | KR101347919B1 | B1 | 2014-01-07 | Espacenet |
| LT | LT3409274T | T | 2020-02-10 | Espacenet |
| LT | LT3453387T | T | 2020-08-25 | Espacenet |
| LT | LT4098256T | T | 2025-06-10 | Espacenet |
| LT | LTPA2020005I1 | I1 | 2020-12-10 | Espacenet |
| LT | LTPA2025520I1 | I1 | 2025-06-25 | Espacenet |
| LU | LUC00183I2 | I2 | 2024-07-01 | Espacenet |
| MA | MA32981B1 | B1 | 2012-01-02 | Espacenet |
| ME | ME03594B | B | 2020-07-20 | Espacenet |
| ME | ME03802B | B | 2021-04-20 | Espacenet |
| MX | MX2011006623A | A | 2011-07-12 | Espacenet |
| MX | MX2021010759A | A | 2022-07-19 | Espacenet |
| MX | MX385959B | B | 2025-03-18 | Espacenet |
| NO | NO2020038I1 | I1 | 2020-11-18 | Espacenet |
| NZ | NZ593065A | A | 2012-11-30 | Espacenet |
| PE | PE20120337A1 | A1 | 2012-04-24 | Espacenet |
| PL | PL2379067T3 | T3 | 2016-02-29 | Espacenet |
| PL | PL3409274T3 | T3 | 2020-06-01 | Espacenet |
| PL | PL3453387T3 | T3 | 2020-11-02 | Espacenet |
| PL | PL4098256T3 | T3 | 2025-06-09 | Espacenet |
| PT | PT2379067E | E | 2015-12-23 | Espacenet |
| PT | PT3409274T | T | 2019-12-17 | Espacenet |
| PT | PT3453387T | T | 2020-08-11 | Espacenet |
| PT | PT4098256T | T | 2025-04-10 | Espacenet |
| RS | RS59857B1 | B1 | 2020-02-28 | Espacenet |
| RS | RS60666B1 | B1 | 2020-09-30 | Espacenet |
| RS | RS66784B1 | B1 | 2025-06-30 | Espacenet |
| RS | RS66784B9 | B9 | 2025-08-29 | Espacenet |
| SG | SG171404A1 | A1 | 2011-07-28 | Espacenet |
| SI | SI2379067T1 | T1 | 2016-01-29 | Espacenet |
| SI | SI3409274T1 | T1 | 2020-03-31 | Espacenet |
| SI | SI3453387T1 | T1 | 2020-10-30 | Espacenet |
| SI | SI4098256T1 | T1 | 2025-06-30 | Espacenet |
| SM | SMT202000054T1 | T1 | 2020-03-13 | Espacenet |
| SM | SMT202000441T1 | T1 | 2020-09-10 | Espacenet |
| TN | TN2011000272A1 | A1 | 2012-12-17 | Espacenet |
| TW | TW201028143A | A | 2010-08-01 | Espacenet |
| US | US2010160259A1 | A1 | 2010-06-24 | Espacenet |
| US | US2011257133A1 | A1 | 2011-10-20 | Espacenet |
| US | US2014066657A1 | A1 | 2014-03-06 | Espacenet |
| US | US2014148415A1 | A1 | 2014-05-29 | Espacenet |
| US | US2016081949A1 | A1 | 2016-03-24 | Espacenet |
| US | US2016263061A1 | A1 | 2016-09-15 | Espacenet |
| US | US2017189353A1 | A1 | 2017-07-06 | Espacenet |
| US | US2018289638A1 | A1 | 2018-10-11 | Espacenet |
| US | US2019091180A1 | A1 | 2019-03-28 | Espacenet |
| US | US2020330407A1 | A1 | 2020-10-22 | Espacenet |
| US | US2022142949A1 | A1 | 2022-05-12 | Espacenet |
| US | US20250262171A1 | A1 | 2025-08-21 | Espacenet |
| UY | UY32352A | A | 2010-07-30 | Espacenet |
| WO | WO2010075239A1 | A1 | 2010-07-01 | Espacenet |
| ZA | ZA201103863B | B | 2012-10-31 | Espacenet |
| ZA | ZA201205942B | B | 2013-03-27 | Espacenet |
Official File Inspection
EPC Art. 128 Public Dossier
Complete European Patent Register Dossier (148 Total Documents)
The full inspection file for Application EP18201062 contains 148 total documents, including all notices of opposition, proprietor counter-statements, examination communications, third-party observations, and procedural forms. Below are all major recorded procedural filings and publication specifications.
Recorded Filings & Patent Specifications
Official publication specifications, opposition filings, proprietor replies, and procedural submissions.
European Patent Specification - Granted Patent (B1)
Publication Specification
Date: 2020-06-03
Procedure: Grant
EP3453387B1
Official European Patent Register Full Dossier
Publication Specification
Date: 2020-06-03
Procedure: All Proceedings (Examination & Opposition)
EP18201062
European Patent Application with Search Report (A1)
Publication Specification
Date: 2019-03-13
Procedure: Publication
EP3453387A1
Revocation of patent
Dossier Filing
Date: 2026-03-06
Procedure: Examination
0009271
New entry: Decision (+date) in appeal procedure
Dossier Filing
Date: 2026-03-03
Procedure: Examination
EPIDOSNNOA9O
Change: Appeal number
Dossier Filing
Date: 2025-04-29
Procedure: Examination
EPIDOSCREFNO
New entry: Date of receipt of statement of grounds of an appeal
Dossier Filing
Date: 2025-04-16
Procedure: Examination
EPIDOSNNOA3O
Deletion: Appeal number
Dossier Filing
Date: 2025-04-16
Procedure: Examination
EPIDOSDREFNO
New entry: Date of receipt of notice of appeal
Dossier Filing
Date: 2025-01-10
Procedure: Examination
EPIDOSNNOA2O
New entry: Payment of appeal fee following opposition
Dossier Filing
Date: 2025-01-10
Procedure: Opposition
EPIDOSNNOA4O
New entry: Despatch of minutes of oral proceedings
Dossier Filing
Date: 2024-12-17
Procedure: Examination
EPIDOSNORA9O
Revocation of the patent
Procedural Step
Date: 2024-12-16
Procedure: Examination
REVO
New entry: Despatch of communication that patent is revoked
Dossier Filing
Date: 2024-12-15
Procedure: Examination
EPIDOSNREV1
Oral proceedings
Procedural Step
Date: 2024-11-26
Procedure: Examination
ORAL
Opposition withdrawn
Dossier Filing
Date: 2024-11-08
Procedure: Opposition
0009264
Opposition withdrawn
Dossier Filing
Date: 2024-10-18
Procedure: Opposition
0009264
Opposition withdrawn
Dossier Filing
Date: 2024-09-06
Procedure: Opposition
0009264
Oral proceedings
Procedural Step
Date: 2024-07-08
Procedure: Examination
ORAL
New entry: Date of oral proceedings
Dossier Filing
Date: 2024-01-25
Procedure: Examination
EPIDOSNORA1O
Deletion: Date of oral proceedings
Dossier Filing
Date: 2024-01-23
Procedure: Examination
EPIDOSDORA1O
Deletion: Date of cancellation oral proceedings
Dossier Filing
Date: 2024-01-23
Procedure: Examination
EPIDOSDORA6O
New entry: Date of cancellation oral proceedings
Dossier Filing
Date: 2024-01-19
Procedure: Examination
EPIDOSNORA6O
New entry: Date of oral proceedings
Dossier Filing
Date: 2023-12-17
Procedure: Examination
EPIDOSNORA1O
Deletion: Date of oral proceedings
Dossier Filing
Date: 2023-12-13
Procedure: Examination
EPIDOSDORA1O
Deletion: Despatch of minutes of oral proceedings
Dossier Filing
Date: 2023-12-13
Procedure: Examination
EPIDOSDORA9O
New entry: Despatch of minutes of oral proceedings
Dossier Filing
Date: 2022-07-15
Procedure: Examination
EPIDOSNORA9O
Oral proceedings
Procedural Step
Date: 2022-06-24
Procedure: Examination
ORAL
New entry: Date of oral proceedings
Dossier Filing
Date: 2021-12-01
Procedure: Examination
EPIDOSNORA1O
Deletion: Date of oral proceedings
Dossier Filing
Date: 2021-11-17
Procedure: Examination
EPIDOSDORA1O
Deletion: Date of cancellation oral proceedings
Dossier Filing
Date: 2021-11-17
Procedure: Examination
EPIDOSDORA6O
New entry: Date of cancellation oral proceedings
Dossier Filing
Date: 2021-11-17
Procedure: Examination
EPIDOSNORA6O
New entry: Date of oral proceedings
Dossier Filing
Date: 2021-11-16
Procedure: Examination
EPIDOSNORA1O
New entry: Reply of patent proprietor to notice(s) of opposition
Dossier Filing
Date: 2021-07-27
Procedure: Opposition
EPIDOSNOBS3
Change - opposition data/opponent's data or that of the opponent's representative
Dossier Filing
Date: 2021-04-16
Procedure: Opposition
0009299OPPO
Invitation to proprietor to file observations on the notice of opposition
Procedural Step
Date: 2021-03-16
Procedure: Opposition
OBSO
New entry: Communication of a notice of opposition and request to file observations + time limit
Dossier Filing
Date: 2021-03-15
Procedure: Opposition
EPIDOSNOBS2
Deletion: Date of oral proceedings
Dossier Filing
Date: 2021-03-12
Procedure: Examination
EPIDOSDORA1O
Deletion: Date of cancellation oral proceedings
Dossier Filing
Date: 2021-03-12
Procedure: Examination
EPIDOSDORA6O
Opposition filed
Dossier Filing
Date: 2021-03-05
Procedure: Opposition
0009260
(Expected) grant
Dossier Filing
Date: 2020-05-01
Procedure: Grant
0009210
New entry: Receipt of the translation of the claim(s)
Dossier Filing
Date: 2020-04-24
Procedure: Examination
EPIDOSNIGR7
New entry: Payment of fee for grant
Dossier Filing
Date: 2020-04-22
Procedure: Grant
EPIDOSNIGR3
New entry: Payment of fee for publishing/printing
Dossier Filing
Date: 2020-04-22
Procedure: Examination
EPIDOSNIGR5
Intention to grant the patent
Procedural Step
Date: 2020-03-31
Procedure: Grant
IGRA
New entry: Communication of intention to grant a patent
Dossier Filing
Date: 2020-03-30
Procedure: Grant
EPIDOSNIGR1
Change - classification
Dossier Filing
Date: 2020-03-13
Procedure: Examination
0008199IPCL
Change - divisional application(s)
Dossier Filing
Date: 2020-03-06
Procedure: Examination
0008199DANR
New entry: Date of cancellation oral proceedings
Dossier Filing
Date: 2020-03-04
Procedure: Examination
EPIDOSNORA6E
Oral proceedings
Procedural Step
Date: 2020-03-04
Procedure: Examination
ORAL
New entry: Renewal fee paid
Dossier Filing
Date: 2019-12-16
Procedure: Examination
EPIDOSNRFE2
Renewal fee payment
Procedural Step
Date: 2019-12-13
Procedure: Examination
RFEE
New entry: Date of oral proceedings
Dossier Filing
Date: 2019-10-23
Procedure: Examination
EPIDOSNORA1E
Change - designated states
Dossier Filing
Date: 2019-09-06
Procedure: Examination
0009199DEST
Change - extension states
Dossier Filing
Date: 2019-09-06
Procedure: Examination
0009199EXPT
New entry: Fee payment for extension state
Dossier Filing
Date: 2019-09-03
Procedure: Examination
EPIDOSNEXP2
Extension of the patent
Procedural Step
Date: 2019-08-30
Procedure: Examination
EXPT
New entry: Reply to examination report
Dossier Filing
Date: 2019-08-05
Procedure: Examination
EPIDOSNEXR3
Communication from the examining division
Procedural Step
Date: 2019-07-25
Procedure: Examination
EXRE
New entry: Despatch of examination report + time limit
Dossier Filing
Date: 2019-07-22
Procedure: Examination
EPIDOSNEXR2
New entry: Reply to examination report
Dossier Filing
Date: 2019-06-07
Procedure: Examination
EPIDOSNEXR3
Change - representative
Dossier Filing
Date: 2019-05-06
Procedure: Examination
EPIDOS FREP
Communication from the examining division
Procedural Step
Date: 2019-04-15
Procedure: Examination
EXRE
First examination report
Dossier Filing
Date: 2019-04-12
Procedure: Examination
0009185
Change - The date on which the examining division becomes responsible, has been established
Dossier Filing
Date: 2019-04-10
Procedure: Examination
EPIDOSCEXAM52
New entry: Despatch of examination report + time limit
Dossier Filing
Date: 2019-04-10
Procedure: Examination
EPIDOSNEXR2
Deletion: Additional fee for renewal fee: despatch of communication + time limit
Dossier Filing
Date: 2019-04-10
Procedure: Examination
EPIDOSDPFE2RFEE
New entry: Additional fee for renewal fee: despatch of communication + time limit
Dossier Filing
Date: 2019-04-01
Procedure: Examination
EPIDOSNPFE2RFEE
New entry: Renewal fee paid
Dossier Filing
Date: 2019-03-29
Procedure: Examination
EPIDOSNRFE2
Renewal fee payment
Procedural Step
Date: 2019-02-17
Procedure: Examination
RFEE
Publication in section I.1 EP Bulletin
Dossier Filing
Date: 2019-02-08
Procedure: Examination
0009012
The date on which the examining division becomes responsible, has been established
Dossier Filing
Date: 2019-02-08
Procedure: Examination
EPIDOSNEXAM52
Request for examination filed
Dossier Filing
Date: 2019-02-08
Procedure: Examination
0009171
Date on which the examining division has become responsible
Procedural Step
Date: 2019-02-01
Procedure: Examination
EXAM52
New entry: Renewal fee paid
Dossier Filing
Date: 2019-01-04
Procedure: Examination
EPIDOSNRFE2
Renewal fee payment
Procedural Step
Date: 2018-12-21
Procedure: Examination
RFEE
New entry: Fee payment for extension state
Dossier Filing
Date: 2018-10-20
Procedure: Examination
EPIDOSNEXP2
New entry: Renewal fee paid
Dossier Filing
Date: 2018-10-20
Procedure: Examination
EPIDOSNRFE2
Change - representative
Dossier Filing
Date: 2018-10-17
Procedure: Examination
EPIDOS FREP
Renewal fee payment
Procedural Step
Date: 2018-10-17
Procedure: Examination
RFEE
Extension of the patent
Procedural Step
Date: 2018-10-17
Procedure: Examination
EXPT
Language of the procedure
Procedural Step
Procedure: Examination
PROL
International searching authority
Procedural Step
Procedure: Examination
ISAT